False
September 10, 2025
Our latest news roundup reports on Novartis’ proposed acquisition of Tourmaline Bio, GLP-1s being added to WHO’s lists of essential medicines, and new safety switches for cell and gene therapies.
3 min read
September 9, 2025
A surge in inspections, a spike in warning letters, and targeted action against high-risk sectors: the FDA’s 2024 report shows global pharma quality is under sharper scrutiny than ever.
4 min read
By Stephanie Vine
September 4, 2025
Paul Offit, a longtime FDA advisor and prominent figure in vaccine development, sidelined from vaccine committee amid healthcare turmoil in the US.
2 min read
September 4, 2025
Increasing demand for GLP-1s sparks surge in illegal distribution
2 min read
September 3, 2025
Our latest news roundup reports on a manufacturing platform that can produce CAR T cells within 24 hours, and stem cells for erectile dysfuntion.
4 min read
September 1, 2025
Orbital experiments are tackling formulation problems, testing monoclonal antibodies, and changing how we think about drug development and crystallization.
4 min read
August 29, 2025
“An entirely new category of weight loss drug.” MitoRx Therapeutics’ weight loss treatments with insulin sensitivity restoration.
2 min read
August 27, 2025
Our latest news roundup reports on the FDA hold on Rocket’s gene therapy study, the closure of Appia, a new gene delivery platform, and more.
2 min read
August 26, 2025
The EMA has maintained its faith in the safe use of titanium dioxide for pharmaceutical applications, but suggests that companies should look into alternatives.
2 min read
August 20, 2025
Our latest news roundup reports on a “quiet” CAR-T project, CRISPR against childhood cancer, and more.
3 min read
False